Human Polyomavirus BKPyV and JCPyV Serostatus Has No Impact on Women´s Human Papillomavirus Infection Outcome

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2023 Jun 19

PMID 37333846

Authors

Hanna K Laine

Tim Waterboer

Kari Syrjanen

Seija Grenman

Karolina Louvanto

Stina Syrjanen

Affiliations

Soon will be listed here.

Abstract

Introduction: Polyomaviruses have both structural and functional similarities with papillomaviruses. Accordingly, their role in human papillomavirus (HPV) associated malignancies has been studied with conflicting results. Our goal was to disclose any association between BK (BKPyV) and/or JC (JCPyV) polyomavirus serology and HPV data derived from Finnish women (327) in a 6-year prospective follow-up.

Methods: Glutathione S-transferase fusion-protein-capture (ELISA) in combination with fluorescent bead technology was used to analyze antibodies to BKPyV and JCPyV. In the longitudinal setting, BKPyV or JCPyV serostatus was related to i) oral- and ii) genital low (LR)- and high risk (HR) HPV DNA detection, iii) HPV16 persistence at both these sites, iv) results of the Pap (Papanicolaou) smear taken at baseline, and v) development of incident CIN (cervical intraepithelial neoplasia) during the follow-up.

Results: Being BKPyV or JCPyV seropositive was not significantly associated with HPV seropositivity to either LR- or HR-genotypes, genital- or oral HPV DNA positivity, persistence of genital- or oral HPV16 infection, grade of Pap smear, or development of incident CIN.

Discussion: Thus, the present study could not provide any confirmation to the concept that co-infections by HPyV and HPV have interactions that impact on the clinical manifestations or outcomes of HPV infections either in the genital tract or in the oral mucosa.

References

Castellsague X, Pawlita M, Roura E, Margall N, Waterboer T, Bosch F . Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort. Int J Cancer. 2013; 135(2):440-52. DOI: 10.1002/ijc.28665. View

Antonsson A, Green A, Mallitt K, ORourke P, Pawlita M, Waterboer T . Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol. 2010; 91(Pt 7):1849-53. DOI: 10.1099/vir.0.020115-0. View

Alosaimi B, Hampson L, He X, Maranga I, Oliver A, Hampson I . Increased prevalence of JC polyomavirus in cervical carcinomas from women infected with HIV. J Med Virol. 2013; 86(4):672-7. DOI: 10.1002/jmv.23868. View

Balis V, Sourvinos G, Soulitzis N, Giannikaki E, Sofras F, Spandidos D . Prevalence of BK virus and human papillomavirus in human prostate cancer. Int J Biol Markers. 2007; 22(4):245-51. DOI: 10.1177/172460080702200402. View

Louvanto K, Syrjanen K, Rintala M, Grenman S, Syrjanen S . Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study. Acta Obstet Gynecol Scand. 2011; 90(2):167-73. DOI: 10.1111/j.1600-0412.2010.01029.x. View

Gossai A, Waterboer T, Nelson H, Michel A, Willhauck-Fleckenstein M, Farzan S . Seroepidemiology of Human Polyomaviruses in a US Population. Am J Epidemiol. 2015; 183(1):61-9. PMC: 5006224. DOI: 10.1093/aje/kwv155. View

Hirsch H, Steiger J . Polyomavirus BK. Lancet Infect Dis. 2003; 3(10):611-23. DOI: 10.1016/s1473-3099(03)00770-9. View

Comar M, Bonifacio D, Zanconati F, Di Napoli M, Isidoro E, Martini F . High prevalence of BK polyomavirus sequences in human papillomavirus-16-positive precancerous cervical lesions. J Med Virol. 2011; 83(10):1770-6. DOI: 10.1002/jmv.22184. View

Llewellyn M, Gordon N, Abbotts B, James N, Zeegers M, Cheng K . Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumours. Sci Rep. 2018; 8(1):11290. PMC: 6062511. DOI: 10.1038/s41598-018-29438-y. View

10.

Wildeman A . Transactivation of both early and late simian virus 40 promoters by large tumor antigen does not require nuclear localization of the protein. Proc Natl Acad Sci U S A. 1989; 86(7):2123-7. PMC: 286863. DOI: 10.1073/pnas.86.7.2123. View

11.

Poluschkin L, Rautava J, Turunen A, Wang Y, Hedman K, Syrjanen K . Polyomaviruses detectable in head and neck carcinomas. Oncotarget. 2018; 9(32):22642-22652. PMC: 5978254. DOI: 10.18632/oncotarget.25202. View

12.

Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, DAntonio D . Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer. 2007; 57(3):273-81. DOI: 10.1016/j.lungcan.2007.02.019. View

13.

Louvanto K, Rintala M, Syrjanen K, Grenman S, Syrjanen S . Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study. J Infect Dis. 2010; 202(3):436-44. DOI: 10.1086/653826. View

14.

Waterboer T, Sehr P, Pawlita M . Suppression of non-specific binding in serological Luminex assays. J Immunol Methods. 2006; 309(1-2):200-4. DOI: 10.1016/j.jim.2005.11.008. View

15.

Kean J, Rao S, Wang M, Garcea R . Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009; 5(3):e1000363. PMC: 2655709. DOI: 10.1371/journal.ppat.1000363. View

16.

Schmitt M, Bravo I, Snijders P, Gissmann L, Pawlita M, Waterboer T . Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol. 2006; 44(2):504-12. PMC: 1392679. DOI: 10.1128/JCM.44.2.504-512.2006. View

17.

Rautava J, Willberg J, Louvanto K, Wideman L, Syrjanen K, Grenman S . Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One. 2012; 7(8):e42171. PMC: 3431392. DOI: 10.1371/journal.pone.0042171. View

18.

Louvanto K, Rautava J, Syrjanen K, Grenman S, Syrjanen S . The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection. Clin Microbiol Infect. 2014; 20(11):1167-72. DOI: 10.1111/1469-0691.12700. View

19.

Polz-Gruszka D, Morshed K, Jarzynski A, Polz-Dacewicz M . Prevalence of Polyoma BK Virus (BKPyV), Epstein-Barr Virus (EBV) and Human Papilloma Virus (HPV) in Oropharyngeal Cancer. Pol J Microbiol. 2016; 64(4):323-8. DOI: 10.5604/17331331.1185229. View

20.

Waterboer T, Sehr P, Michael K, Franceschi S, Nieland J, Joos T . Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem. 2005; 51(10):1845-53. DOI: 10.1373/clinchem.2005.052381. View